| |
|
Form Serial Number: |
DA20240902E00327
|
| 1.
Date of relevant event: |
20/08/2024
(dd/mm/yyyy)
|
| 2.
Date when director became aware of the relevant event/ interest in the shares (if later): |
(dd/mm/yyyy)
|
| 3.
Stock code: |
02410 |
| 4.
Name of listed corporation: |
TYK Medicines, Inc - B - H Shares |
| 5.
Class of shares: |
Others |
| 6.
Number of issued shares in class: |
178,249,645 |
| 7.
Name of director (English) as printed on HKID Card/Passport: |
| (Surname) |
WU |
| (Other names) |
Yusheng |
|
|
|
| 10.
Name of director (Chinese): |
吳豫生 |
| 11.
Chinese Character Code as printed on HKID Card: |
|
| |
| 24.
Details of relevant event: |
|
|
Brief description of relevant event
|
Capacity in which shares were/are held
|
Number of shares bought/sold or involved
|
Currency of transaction |
On Exchange
|
Off Exchange
|
|
Before relevant event
|
After relevant event
|
Highest price (per share)
|
Average price (per share)
|
Average consideration (per share)
|
Consideration code
|
| Long position |
| 1701 | Miscellaneous
On listing of the corporation or a class of shares of the listed corporation |
|
|
| 2201 | Interest of corporation controlled by you |
|
85,312,500 |
|
|
|
|
|
| Short position |
|
|
|
|
|
|
|
|
|
| |
|
| 25.
Total shares in listed corporation immediately before the relevant event: |
| | Total number of shares | Percentage figure (%) |
| | | |
|
| |
| 26.
Total shares in listed corporation immediately after the relevant event: |
| | Total number of shares | Percentage figure (%) |
| Long position | 85,312,500 | 47.86 |
|
| |
| 27.
Capacity in which interests disclosed in Box 26 are held: |
| Code describing capacity | Number of shares |
| 2201 | Interest of corporation controlled by you |
| |
|
| |
| 28.
Further information in derivative interests in listed corporation : |
| Derivatives code |
Exercise period (dd/mm/yyyy) |
Consideration - if derivatives granted by listed corporation |
Number of shares |
| | | Begins | Ends | Currency | Price for grant | Currency | Exercise price | Currency | Price on assignment | |
| | | | | | | | | | | |
|
| |
| 29.
Further information in relation to interests of children under 18 and/or spouse: |
| Child/Spouse | Name of child/spouse | Number of shares |
| | |
|
| |
| 30.
Further information in relation to interests of corporations controlled by Director: |
| Name of controlled corporation | Address and place of incorporation | Name of controlling person | % control | Direct interest (Y/N) | Number of shares |
| Tetranov Pharmaceutical (Zhengzhou) Co., Ltd. (鄭州泰基鴻諾醫藥股份有限公司) | 鄭州市航空港區生物科技二街鄭州臨空生物醫藥園14號樓B棟 (PRC) | WU Yusheng (吳豫生) | 30.66 | Y | |
| Tetranov Pharmaceutical (Zhengzhou) Co., Ltd. (鄭州泰基鴻諾醫藥股份有限公司) | 鄭州市航空港區生物科技二街鄭州臨空生物醫藥園14號樓B棟 (PRC) | Zhengzhou Hongnuo Enterprise Management Consulting Center (Limited Partnership) (鄭州鴻諾企業管理諮詢中心(有限合夥)) | 20.15 | Y | |
| Tetranov Pharmaceutical (Zhengzhou) Co., Ltd. (鄭州泰基鴻諾醫藥股份有限公司) | 鄭州市航空港區生物科技二街鄭州臨空生物醫藥園14號樓B棟 (PRC) | Zhengzhou Derui Medical Technology Co., Ltd. (鄭州德瑞醫藥科技有限公司) | 3.02 | Y | |
| Zhengzhou Derui Medical Technology Co., Ltd. (鄭州德瑞醫藥科技有限公司) | 鄭州市二七區大學路75號院25號樓1單元5號 (PRC) | WU Yusheng (吳豫生) | 100.00 | N | |
| Huzhou Derui Medical Technology Co., Ltd. (湖州德瑞醫藥科技有限公司) | 浙江省湖州市長興縣經濟開發區明珠路1278號長興太湖資本廣場1402-8室 (PRC) | Zhengzhou Derui Medical Technology Co., Ltd. (鄭州德瑞醫藥科技有限公司) | 99.75 | N | |
| Zhengzhou Hongnuo Enterprise Management Consulting Center (Limited Partnership) (鄭州鴻諾企業管理諮詢中心(有限合夥)) | 鄭州市二七區大學路75號院25號樓1單元5號 (PRC) | Huzhou Derui Medical Technology Co., Ltd. (湖州德瑞醫藥科技有限公司) | 100.00 | N | |
| Changxing Liyuan Enterprise Management Partnership (Limited Partnership) (長興利源企業管理合夥企業(有限合夥)) | 浙江省湖州市長興縣經濟開發區明珠路1278號長興世貿大廈A座14層1403-8室 (PRC) | Zhengzhou Derui Medical Technology Co., Ltd. (鄭州德瑞醫藥科技有限公司) | 100.00 | Y | |
| Changxing Caiyuan Enterprise Management Partnership (Limited Partnership) (長興彩源企業管理合夥企業(有限合夥)) | 浙江省湖州市長興縣開發區明珠路1278號長興世貿大樓A座11樓1108-73室 (PRC) | Huzhou Derui Medical Technology Co., Ltd. (湖州德瑞醫藥科技有限公司) | 100.00 | Y | |
| Changxing Gangyuan Enterprise Management Partnership (Limited Partnership) (長興罡源企業管理合夥企業(有限合夥)) | 浙江省湖州市長興縣開發區明珠路1278號長興世貿大樓A座11樓1108-74室 (PRC) | Huzhou Derui Medical Technology Co., Ltd. (湖州德瑞醫藥科技有限公司) | 100.00 | Y | |
|
| |
| 31.
Further information in relation to interests held by Director jointly with another person: |
| Name of joint shareholder | Address | Number of shares |
| | |
|
| |
| 32.
Further information from a director who is a trustee, or beneficiary of a trust, or a person who has set up a Discretionary Trust: |
| Names of Trust | Address | Status code | Number of shares |
| | | |
|
| |
| 33.
Further information from a party to an agreement under Section 317 (Please see Notes for further information required): |
| Names of other parties | Address | Number of shares |
| | |
| Total number of shares in which a director is interested under sections 317 and 318 | |
|
| |
| 34.
Supplementary information: |
Box 5: "Others" refer to Unlisted Shares of TYK Medicines, Inc
|
| 35.
Log/Serial Number of the previous form: |
|
| 36.
Number of concert party document(s) under section 317 attached/uploaded: |
|
|
Date of filing this Form 3A: |
02/09/2024
(dd/mm/yyyy)
|
| |